Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways (Q40569795)

21 September 2017

title

Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways (English)

1 reference

21 September 2017

1 reference

1 reference

10

Francis W Ruscetti

1 reference

21 September 2017

7

Daniel C Bertolette

1 reference

21 September 2017

author name string

Maria C Birchenall-Roberts

1

1 reference

21 September 2017

Tao Fu

2

1 reference

21 September 2017

Ok-Sun Bang

3

1 reference

21 September 2017

Michael Dambach

4

1 reference

21 September 2017

James H Resau

5

1 reference

21 September 2017

Cari L Sadowski

6

1 reference

21 September 2017

Ho-Jae Lee

8

1 reference

21 September 2017

Seong-Jin Kim

9

1 reference

21 September 2017

language of work or name

English

0 references

publication date

2 April 2004

1 reference

Journal of Biological Chemistry

21 September 2017

published in

1 reference

21 September 2017

volume

279

1 reference

21 September 2017

issue

24

1 reference

21 September 2017

page(s)

25605-25613

1 reference

A role of the tuberous sclerosis gene-2 product during neuronal differentiation

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

New developments in the neurobiology of the tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Signal transduction by the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

TGF-beta signaling: positive and negative effects on tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Transforming growth factor beta, pleiotropic regulator of hematopoietic stem cells: potential physiological and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

GAL4-VP16 is an unusually potent transcriptional activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Nuclear localization of v-Abl leads to complex formation with cyclic AMP response element (CRE)-binding protein and transactivation through CRE motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Intracellular signalling: the mad way to do it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Cyclin A down-regulation in TGFbeta1-arrested follicular lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Germ-Line Mutational Analysis of the TSC2 Gene in 90 Tuberous-Sclerosis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.M402790200

21 January 2018

Identifiers

DOI

10.1074/JBC.M402790200

1 reference

21 September 2017

1 reference